Merkoša sitáhtat
APA-čujuhus (7. p.)
Wang, P., Wang, R., Zhao, W., Zhao, Y., Wang, D., Zhao, S., . . . Zhao, X. (2025). Gut microbiota-derived 4-hydroxyphenylacetic acid from resveratrol supplementation prevents obesity through SIRT1 signaling activation. Taylor & Francis Group.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Chicago-čujuhus (17. p.)
Wang, Pan, Ruiqi Wang, Wenting Zhao, Yuanyuan Zhao, Dan Wang, Shuang Zhao, Zhiwen Ge, Yue Ma, juo Xiaoyan Zhao. Gut Microbiota-derived 4-hydroxyphenylacetic Acid from Resveratrol Supplementation Prevents Obesity Through SIRT1 Signaling Activation. Taylor & Francis Group, 2025.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
MLA-čujuhus (9. p.)
Wang, Pan, et al. Gut Microbiota-derived 4-hydroxyphenylacetic Acid from Resveratrol Supplementation Prevents Obesity Through SIRT1 Signaling Activation. Taylor & Francis Group, 2025.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.